| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.5 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.18 | 0.5 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.5 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.5 |